To access this element change to forms mode OFF
Grant Award View - GA294521
Exploring biomarkers, therapeutic targets, and modifiable risk factors...
GA ID:
GA294521
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
13-Feb-2023
Publish Date:
11-Apr-2023
Category:
Medical Research
Grant Term:
1-Apr-2023 to 31-Mar-2026
Value (AUD):
$499,806.80
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 21/22 1.1 Health and Medical Research
Grant Program:
International Joint Calls
Grant Activity:
Exploring biomarkers, therapeutic targets, and modifiable risk factors for non-Alzheimer's dementia
Purpose:
There are various form of dementia, e.g. Alzheimer's disease (AD), vascular dementia (VaD), and frontotemporal dementia (FTD). AD has been a research focus in the last decade as it is the major form of dementia, while there is far less research progress in VaD and FTD. Our project aims to improve understanding on VaD and FTD, focusing on accurate diagnosis, potential therapeutic targets and modifiable risk factors, with the ultimate goal to improve quality of life of people living with dementia.
GO ID:
GO Title:
NHMRC-AMED 2022 Dementia Collaborative Research Scheme funding commencing in 2022
Internal Reference ID:
2023/GNT2022203
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, VIC, WA
Postcode:
Multiple
Country:
AUSTRALIA